tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Precision BioSciences (DTIL)
NASDAQ:DTIL
US Market
DTIL
Precision BioSciences
Overview
Analyst Forecasts
Financials
Dividends
Technical Analysis
Options
Chart
Earnings
Ownership
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Precision BioSciences (DTIL) Stock News & Sentiment

Compare
729 Followers
Buy Rating for Precision BioSciences: Promising Clinical Data and Undervaluation Highlight Favorable Risk/Reward Scenario
Premium
Ratings
Buy Rating for Precision BioSciences: Promising Clinical Data and Undervaluation Highlight Favorable Risk/Reward Scenario
11d ago
DTIL
Encouraging Initial Data for Precision BioSciences’ PBGENE-HBV Supports Positive Analyst Rating and $60 Target Price
Premium
Ratings
Encouraging Initial Data for Precision BioSciences’ PBGENE-HBV Supports Positive Analyst Rating and $60 Target Price
12d ago
DTIL
Positive Outlook for Precision BioSciences: Promising Gene-Editing Therapy for Hepatitis B and Strong Financial Position
Premium
Ratings
Positive Outlook for Precision BioSciences: Promising Gene-Editing Therapy for Hepatitis B and Strong Financial Position
12d ago
DTIL
Precision Biosciences (DTIL) Q3 Earnings Cheat Sheet
Premium
Pre-Earnings
Precision Biosciences (DTIL) Q3 Earnings Cheat Sheet
4M ago
DTIL
Precision BioSciences Advances Gene Editing Trials Globally
Premium
Company Announcements
Precision BioSciences Advances Gene Editing Trials Globally
4M ago
8K
DTIL
Precision BioSciences Reshuffles Clinical Leadership Team
Premium
Company Announcements
Precision BioSciences Reshuffles Clinical Leadership Team
6M ago
8K
DTIL
Precision BioSciences Secures Funds, Bolsters Oncology Partnership
Premium
Company Announcements
Precision BioSciences Secures Funds, Bolsters Oncology Partnership
6M ago
8K
DTIL
More DTIL News >

DTIL News on the Web

Precision BioSciences Announces Oral Presentation at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference
Yahoo Finance
Neutral
Precision reports initial outcomes from Hepatitis B trial of PBGENE-HBV
Clinical Trials Arena
Neutral
Precision BioSciences Touts Encouraging Initial Safety And Antiviral Activity Of Hepatitis B Treatment Candidate
Yahoo Finance
Neutral
Precision BioSciences Announces Initial Safety and Antiviral Activity of PBGENE-HBV in the ELIMINATE-B Clinical Trial
Yahoo Finance
Neutral
Lynx1 Capital Management LP Acquires Significant Stake in Precision BioSciences Inc
GuruFocus News
Neutral
Precision BioSciences Strengthens Senior Leadership Team to Drive Multiple In Vivo Gene Editing Programs
Yahoo Finance
Neutral
Strong Buy Recommendation for Precision BioSciences: Promising Clinical Data and Favorable Valuation
TipRanks News
Bullish
Precision gains CTA approval in Hong Kong for chronic hepatitis B therapy trial
Clinical Trials Arena
Neutral

News Score - Last 7 Days

Neutral
DTIL
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week50%
Sector Average55%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DTIL’s Media Buzz Sentiment?
Currently, no data Available
What is DTIL’s weekly average amount of articles?
Currently, no data Available
What is DTIL’s News Sentiment?
50% of articles about DTIL were positive this week, compared to its sector average of 55%.
    Healthcare Stocks that are Trending in the News
    JAZZJazz Pharmaceuticals
    CCCCC4 Therapeutics
    MASIMasimo
    CADLCandel Therapeutics
    CORTCorcept Therapeutics
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing